Aemetis, Inc

AMTX Basic Materials Specialty Chemicals

Aemetis, Inc’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, down 26.2% from fiscal 2024.

Revenue
+48.9%
EPS
+118.9%
Free cash flow
+269.0%
Total debt
+12.6%

Quarter to September 2026, against a year earlier

1.62 0.11 −6.36%
Market cap
$124.9M
P/E
0.0×
Fwd P/E
−1.4×
Dividend yield
—
F-score
4/9
Altman Z
−4.66
Beneish M
n/a
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
Revenue
88.15 62.70 54.62 43.31

+8 more quarters

Revenue Growth
48.93% 20.02% 27.36% (7.87%)
Gross Profit
29.47 13.52 2.76 7.73
Operating Income
20.85 5.77 (6.33) (2.48)
EBT
5.21 (9.37) (21.84) (16.77)
Income after Tax
5.21 (9.37) (21.71) (5.33)
Net Income Common
5.21 (9.37) (21.71) (5.33)
EPS (Diluted)
0.07 (0.13) (0.33) (0.08)
Shares (Diluted, Weighted)
72.50 70.89 66.80 59.98
Gross Margin
33.43% 21.56% 5.05% 17.84%
EBIT Margin
23.65% 9.21% (11.60%) (5.73%)
Net Profit Margin
5.91% (14.94%) (39.75%) (12.31%)
EBITDA
— 8.67 (1.83) 2.00
EBIT
20.85 5.77 (6.33) (2.48)

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Nov 2026